MBX Biosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $75.3M | $49.4M | $30.5M |
| Accounts Receivable | — | — | — |
| Inventory | — | — | — |
| Total Current Assets | $381.5M | $267.3M | $83.5M |
| Property, Plant & Equipment | $2.7M | $1.1M | $439.0K |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $385.1M | $268.5M | $84.2M |
| Liabilities | |||
| Accounts Payable | $3.0M | $5.3M | $1.4M |
| Total Current Liabilities | $15.5M | $11.1M | $3.9M |
| Long-Term Debt | — | — | — |
| Total Liabilities | $15.9M | $11.1M | $4.3M |
| Stockholders' Equity | |||
| Retained Earnings | $-224.5M | $-137.5M | $-75.6M |
| Total Stockholders' Equity | $369.2M | $257.4M | $-72.5M |